Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil

Journal of Clinical Microbiology

Volumn 41, Issue 7, 2003, Pages 3403-3406

  Dalia Costa, Libera M ^a   Coelho, Juliana M ^c   Souza, Helena A P H M ^a   Castro, Maria E S ^a   Stier, Christiane J N ^a   Bragagnolo, Karin L ^a   Rea Neto, Alvaro ^a   Penteado Filho, Sergio R ^b   Livermore, David M ^c   Woodford, Neil ^c  

^a Universidade Federal   (Argentina)

^b HOSPITAL UNIVERSITÁRIO EVANGÉLICO DE CURITIBA   (Brazil)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Y

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; BACTERIAL ENZYME; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CLINDAMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; METRONIDAZOLE; OXA 23 CABAPENEMASE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; UNCLASSIFIED DRUG; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BONE INFECTION; BRAZIL; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; LUNG INFECTION; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; BRAZIL; CARBAPENEMS; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; HOSPITALS, TEACHING; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

ACINETOBACTER; ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 0038494600     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.7.3403-3406.2003     Document Type: Article

References (16)

1. Afzal-Shah, M., H. E. Villar, and D. M. Livermore. 1999. Biochemical characteristics of a carbapenemase from an Acinetobacter baumannii isolate collected in Buenos Aires, Argentina. J. Antimicrob. Chemother. 43:127-131.
2. Afzal-Shah, M., N. Woodford, and D. M. Livermore. 2001. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45:583-588.
3. Bergogne-Berezin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
4. Bonnet, R., H. Marchandin, C. Chanal, D. Sirot, R. Labia, C. De Champs, E. Jumas-Bilak, and J. Sirot. 2002. Chromosome-encoded class D betalactamase OXA-23 in Proteus mirabilis. Antimicrob. Agents Chemother. 46: 2004-2006.
5. Bou, G., A. Oliver, and J. Martinez-Beltran. 2000. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob. Agents Chemother. 44:1556-1561.
6. Donald, H. M., W. Scaife, S. G. Amyes, and H. K. Young. 2000. Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob. Agents Chemother. 44:196-199.
7. Garcia, I., V. Fainstein, B. LeBlanc, and G. P. Bodey. 1983. In vitro activities of new beta-lactam antibiotics against Acinetobacter spp. Antimicrob. Agents Chemother. 24:297-299.
8. Gouby, A., M. J. Carles-Nurit, N. Bouziges, G. Bourg, R. Mesnard, and P. J. Bouvet. 1992. Use of pulsed-field gel electrophoresis for investigation of hospital outbreaks of acinetobacter baumannii. J. Clin. Microbiol. 30:1588-1591.
9. Levin, A. S., A. A. Barone, J. Penco, M. V. Santos, I. S. Marinho, E. A. Arruda, E. I. Manrique, and S. F. Costa. 1999. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis. 28:1008-1011.
10. Levin, A. S., C. M. Mendes, S. I. Sinto, H. S. Sader, C. R. Scarpitta, E. Rodrigues, N. Sauaia, and M. Boulos. 1996. An outbreak of multiresistant Acinetobacter baumanii in a university hospital in Sao Paulo, Brazil. Infect. Control Hosp. Epidemiol. 17:366-368.
11. Livermore, D. M. 2002. The impact of carbapenemases on antimicrobial development and therapy. Curr. Opin. Investig. Drugs 3:218-224.
12. a. Lopez-Otsoa, F., L. Gallego, K. J. Towner, L. Tysall, N. Woodford, and D. M. Livermore. 2002. Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain. 40:4741-4743.
13. Paton, R. H., R. S. Miles, J. Hood, and S. G. Amyes. 1993. ARI-1:β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents 2:81-88.
14. Poirel, L., and P. Nordmann. 2002. Acquired carbapenem-hydrolyzing betalactamases and their genetic support. Curr. Pharm. Biotechnol. 3:117-127.
15. 1MP) in gram-negative rods resistant to broad-spectrum beta-lactams. J. Clin. Microbiol. 34:2909-2913.
16. Tsakris, A., S. Pournaras, N. Woodford, M. F. Palepou, G. S. Babini, J. Douboyas, and D. M. Livermore. 2000. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38:1290-1292.